Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 7,569 shares of the firm's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of C$9.71, for a total value of C$73,503.54.
Rostislav Christov Raykov also recently made the following trade(s):
- On Wednesday, February 5th, Rostislav Christov Raykov sold 2,431 shares of Fennec Pharmaceuticals stock. The shares were sold at an average price of C$9.66, for a total transaction of C$23,476.17.
- On Monday, January 6th, Rostislav Christov Raykov sold 10,000 shares of Fennec Pharmaceuticals stock. The stock was sold at an average price of C$8.76, for a total transaction of C$87,552.00.
- On Friday, December 20th, Rostislav Christov Raykov bought 25,000 shares of Fennec Pharmaceuticals stock. The shares were purchased at an average cost of C$3.87 per share, with a total value of C$96,840.00.
Fennec Pharmaceuticals Price Performance
Shares of Fennec Pharmaceuticals stock opened at C$9.43 on Friday. Fennec Pharmaceuticals Inc. has a 52-week low of C$5.65 and a 52-week high of C$15.20. The stock has a market capitalization of C$181.85 million, a price-to-earnings ratio of -159.74 and a beta of 0.25. The company has a fifty day moving average of C$9.17 and a 200-day moving average of C$7.87. The company has a debt-to-equity ratio of -620.83, a quick ratio of 10.17 and a current ratio of 7.80.
Wall Street Analysts Forecast Growth
Separately, Stephens upgraded shares of Fennec Pharmaceuticals to a "strong-buy" rating in a research note on Monday, November 18th.
View Our Latest Stock Report on FRX
Fennec Pharmaceuticals Company Profile
(
Get Free Report)
Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
